- Treatment Options
- Ablation Therapy
- Angiogenesis Inhibitors
- Awake Craniotomy
- Brachytherapy
- Breast Reconstruction Surgery
- CAR T Cell Therapy
- Chemotherapy
- Cryoablation
- High-Intensity Focused Ultrasound (HIFU)
- Histotripsy
- Hyperthermic Intraperitoneal Chemotherapy
- Immunotherapy
- Immune Checkpoint Inhibitors
- Integrative Medicine
- Interventional Oncology
- Laser Interstitial Thermal Therapy (LITT)
- Microwave Ablation
- Minimally Invasive Surgery
- MR-Linac Radiation Therapy
- Palliative Care
- Proton Therapy
- Radiation Therapy
- Radiofrequency Ablation
- Stem Cell (Bone Marrow) Transplantation
- Stereotactic Body Radiation Therapy
- Stereotactic Radiosurgery
- Surgery
- Targeted Therapy
- Y90 Radioembolization
Brachytherapy
Brachytherapy is a type of internal radiation therapy where tiny radioactive sources are placed within the body to treat cancer. These sources, or seeds, are about the size of a grain of rice. The source is positioned precisely on or inside the patient’s body, close to or inside the tumor. In some cases, the sources remain in place for just a few minutes. This requires an applicator or hollow tube, which is removed after the treatment is complete. In other cases, the radioactive seeds slowly decay and become not radioactive. These seeds can be left in place permanently.
Brachytherapy allows doctors to deliver radiation directly to the patient’s tumor while limiting radiation exposure to healthy tissue.
Brachytherapy is typically used when the tumor is easy to reach with minimally invasive techniques, such as the use of an applicator device or needle. It is a common treatment for prostate cancer and gynecologic cancers including cervical cancer, endometrial cancer and vaginal cancer, among other diseases.
Types of brachytherapy
There are three primary ways doctors deliver brachytherapy:
- Low-dose brachytherapy (LDR) places the radioactive pellets in or near the tumor permanently. These seeds are radioactive for a few weeks to several months. Patients undergo this as an outpatient procedure. After the sources are placed, patients can resume their normal activities.
- Pulsed-dose brachytherapy (PDR) requires a hospital stay. At the start of the stay, doctors place an applicator device in or near the tumor. A machine then sends the radioactive pellets into the applicator for roughly 10-15 minutes every hour for about two days. The procedure may be repeated after a few weeks.
- High-dose brachytherapy (HDR) also uses an applicator device. The radiation from the pellet is more powerful than pulsed-dose, so the patient receives just one approximately 10-minute exposure every few days for two to three weeks. High-dose brachytherapy is an outpatient procedure.
Brachytherapy side effects
Side effects for brachytherapy are usually limited to the area near where the sources are placed. For example, cervical cancer patients who receive brachytherapy may experience bladder problems such as discomfort when urinating.
Appointments & Referrals
Visit our appointments page to learn about new patient appointments and physian referrals
Brachytherapy for gynecologic cancers
Brachytherapy is a common treatment for many gynecologic cancers, including cervical, uterine and vaginal cancers. It is standard for cervical cancer patients to receive brachytherapy after external beam radiation therapy. Uterine cancer patients who can’t undergo surgery also get brachytherapy. Some patients with endometrial cancer will receive brachytherapy after surgery.
For patients who haven’t had surgery, gynecologic brachytherapy starts with the patient being put under general anesthesia. A radiation oncologist precisely places an applicator inside the patient’s vagina or uterus (depending on the type of cancer), as close to the tumor as possible. Advanced imaging technologies (such as MRI, ultrasound and CT Scans) help ensure the applicator is positioned to deliver the most effective dose of radiation, as well as determine the dose itself.
The applicator is then attached to a machine that holds a small radioactive pellet. The pellet is sent into the applicator for a short amount of time, where it irradiates the tumor before being pulled back into the machine.
Brachytherapy for cervical cancer
Patients undergoing treatment for cervical cancer typically receive brachytherapy treatment through internal radiation therapy implants. These are delivered via an applicator that is inserted into the uterus through the vagina. The implants may be inserted under general anesthesia
Depending on the patient’s specific condition, doctors will recommend one of two approaches to this treatment. Pulsed-dose rate (PDR) brachytherapy is a two-day inpatient procedure that sends the radioactive pellet into the applicator for 15 minutes every hour. PDR patients undergo this process two times about two weeks apart.
High-dose rate brachytherapy uses a pellet with more active radiation. It is sent into the applicator just one time for 10 minutes. Patients undergo this procedure as an outpatient five times over two to three weeks. Your radiation oncologist can discuss the best approach for your treatment.
Brachytherapy for endometrial cancer
Brachytherapy is also used to treat endometrial cancer following a hysterectomy to eliminate any cancer cells that may remain after surgery. This is a simpler procedure where a small dome is placed into the vagina while the patient is awake. A radioactive source runs into this dome to deliver high-dose brachytherapy.
Though doctors do their best to prevent radiation from impacting healthy tissue, brachytherapy for gynecologic cancers can have some short-term side effects, including soreness where the applicator was placed or a small amount of bleeding. In the long term, radiation can cause diarrhea and blood in urine or stool. If these symptoms develop and don’t resolve with medications, your oncologist may refer you to a gastroenterologist or urologist to diagnose or treat the problem.
Brachytherapy for prostate cancer
Brachytherapy has been used as a primary treatment for low- and intermediate-risk prostate cancer for several years. To qualify for this treatment, a patient’s cancer cannot have spread significantly outside the prostate. Doctors will also perform a physical exam, imaging exams and evaluate current urinary symptoms to determine if this is the best treatment for the patient.
For prostate cancer patients receiving low-dose brachytherapy (LDR) brachytherapy, small pieces of radioactive material (usually about the size of a grain of rice) are placed inside the patient’s body as close to the tumor as possible. This allows doctors to deliver very high doses of radiation directly to the patient’s tumor while limiting radiation exposure to healthy tissue. The implants are given under general anesthesia. Some patients get brachytherapy alone, while others get brachytherapy following external radiation treatment.
For prostate cancer patients receiving high-dose brachytherapy (HDR) treatment, the applicators, or thin needles, are placed into the prostate gland. After insertion, the HDR treatment is delivered by the source running into the applicator for 5-10 minutes.
Recent studies also show brachytherapy is effective as an end-of-treatment “boost” for patients with high-risk diseases. This boost follows external beam radiation therapy and decreases the risk of the disease progressing.
After treatment, patients may experience temporary urinary side effects. These include burning, frequent urination, urgent urination and a weak stream. They are managed with medication and typically go away a few months after treatment.
MRI-assisted radiosurgery and brachytherapy for prostate cancer treatment
Many prostate cancer patients getting brachytherapy undergo MRI-assisted radiosurgery (MARS). This procedure uses a permanent, implantable MRI marker to improve the precision of brachytherapy for prostate cancer. By using MRI to assist in placing seeds in patients, doctors can better visualize the tumor during treatment. This helps them limit radiation exposure to surrounding healthy tissue near the prostate. MRI is used at every step of the process, including diagnosis, treatment planning, treatment delivery and post-treatment assessment.
Brachytherapy at MD Anderson
Choosing where to go for cancer care is one of the most important decisions you can make. At MD Anderson, our focus on each patient’s experience and comfort during the process is unique, with a dedicated team that cares for our brachytherapy patients. As part of a top-ranked cancer center, our team of doctors has access to the most advanced technologies, allowing them to deliver the most effective treatment while minimizing side effects.
MD Anderson provides highly personalized treatment plans using cutting-edge technology, and advanced imaging with intraoperative CT (ioCT), intraoperative magnetic resonance imaging (ioMRI) and the MR-LINAC, the first MRI integrated with radiation therapy delivery in the United States, for advanced cancer treatment and research.
Our treatment options for gynecologic brachytherapy are personalized to each patient’s preferences and clinical situation. We have access to several types of brachytherapy applicators, allowing us to choose the best option for each patient.
Our team of experts can adapt the brachytherapy treatment plan based on each individual tumor. We use high-quality imaging techniques and a variety of inpatient and outpatient options to develop the best plan for each patient.
And at MD Anderson you will be surrounded by the strength of one of the nation's largest and most experienced cancer centers. From support groups to counseling to integrative medicine care, we have all the services needed to treat not just the disease, but the whole person.
request an appointment online.
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.